NVAXCIK 1000694

NOVAVAX INC

EDGAR filings

Customers

1 active

Suppliers

None disclosed

Largest customer

36%

SNY · FY to 2025-12-31

Named-customer revenue

$404.5M

1 customer · FY to 2025-12-31

Latest period

Dec 31, 2025

10-K filed 2026-02-26

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available). Thin bands are named without a figure. Click a band to open its filing.

Customers 3

Companies NVAX discloses as major customers, as a share of NVAX revenue. 1 active, 2 lapsed.

Company	% of NVAX revenue	Est. revenue	Period	Trend	Status	Source
SNY Sanofi	36%	$404.5M	FY 2025-12-31	−32.0pp	Active	10-K 2026-02-26
Sanofi 36 % 68 % * 76 % 46 % 10-K filed 2026-02-26 Period FY 2025-01-01 to 2025-12-31 (36%), FY 2024-01-01 to 2024-12-31 (68%)Accession 0001000694-26-000007
CAH Distributor CARDINAL HEALTH INC	Named	—	FY 2024-12-31	—	Lapsed Last seen 2024-12-31	10-K 2026-02-26
Cardinal Health * * * * 10 % 10-K filed 2026-02-26 Period FY 2024-01-01 to 2024-12-31Accession 0001000694-26-000007
MCK Distributor MCKESSON CORP	Named	—	FY 2024-12-31	—	Lapsed Last seen 2024-12-31	10-K 2026-02-26
McKesson Plasma and Biologics * * * * 14 % 10-K filed 2026-02-26 Period FY 2024-01-01 to 2024-12-31Accession 0001000694-26-000007

Alerts are coming

Get an email when NVAX's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.